Clorazepate Dipotassium
Product Images NDC 67046-904

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clorazepate Dipotassium (NDC 67046-904). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30's Bottle Label (Clorazep2)

Label for Clorazepate dipotassium 7.5 mg tablets, package of 30 count. The label states it is a controlled substance with an expiration date of 09/30/13, lot number 2329250, and pill ID RX 553. The labeler is Contract Pharmacy Services-PA, located in Warrington, PA. Storage instructions specify 20-25°C (68-77°F). The usual dosage advises consulting the package insert for full prescribing information.*

FDA Label Image

30's Bottle Label (Clorazep3)

Label for Clorazepate 15 mg tablets, bottle count 30, labeled as a controlled substance (Schedule IV) by Contract Pharmacy Services-PA. Includes lot number 2366284, expiration date 12/31/13, storage instructions at 20-25°C, and mentions full prescribing info on package insert. Manufacturer shown as Ranbaxy.*

FDA Label Image

Structural Formula (Strucutre)

Chemical structure diagram of Clorazepate dipotassium showing its molecular arrangement including chlorophenyl, carbamoyl, and dipotassium components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.